Quest Diagnostics Q4 2024 Earnings Report Highlights Growth and Strategic Acquisitions

Quest Diagnostics (DGX) reported 15% revenue growth in Q4 2024, with 5% organic growth, and 7% full-year revenue growth. The company completed eight acquisitions, including LifeLabs in Canada, and expanded its diagnostic services. The earnings call highlighted improvements in profitability, automation, and employee retention.

By Motley Fool Transcribing, The Motley Fool Tue, April 21, 2026 at 6:26 PM GMT+3 40 min read · Yahoo Finance ·

Quest Diagnostics Q4 2024 Earnings Report Highlights Growth and Strategic Acquisitions

Tickers: $DGX

Topics: acquisitions earnings call financial guidance profitability revenue growth

Read the full article at Yahoo Finance

More World news